US Patent Issued to Dana-Farber Cancer Institute on Dec. 30 for "Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,455, issued on Dec. 30, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof" was invented by Nathanael S. Gray (Boston), Tinghu Zhang (Brookline, Mass.), Yao Liu (Brookline, Mass.), Zhixiang He (Brookline, Mass.), Mingfeng Hao (Hefei, China), David Weinstock (Jamaica Plain, Mass.) and Loretta Sze-Mun Li (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds of Formula (I') (e.g., compounds of Formula (I)), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, cocrystals, ta...